Visceral leishmaniasis (VL) is a systemic protozoan disease that is transmitted by
phlebotomine sandflies. Poor and neglected populations in East Africa and the Indian sub-continent …

Background Neglected tropical diseases (NTDs) are a group of chronic parasitic diseases
and related conditions that are the most common diseases among the 2·7 billion people …

Background Visceral leishmaniasis (VL) is a major health problem in developing countries.
The untreated disease is fatal, available treatment is expensive and often toxic, and drug …

Kinetoplastid parasites have caused human disease for millennia. Significant achievements
have been made toward developing new treatments for leishmaniasis (particularly on the …

Interferon (IFN)-gamma plays an important role during immune responses against leishmaniasis.
Production of IFN-gamma is regulated by interleukin (IL)-12, IL-18, and IL-15. Interferon…

Giardia duodenalis, a flagellated protozoan, represents a common cause of gastroenteritis in
Ethiopia, however very little information is available on the epidemiology and transmission …

Background Alternative treatments for visceral leishmaniasis (VL) are required in East Africa.
Paromomycin sulphate (PM) has been shown to be efficacious for VL treatment in India. …

Visceral Leishmaniasis (VL) is an important protozoan opportunistic disease in HIV patients
in endemic areas. East Africa is second to the Indian subcontinent in the global VL caseload …

Potential toxicity, costs, and drug‐resistant pathogens necessitate the development of new
antileishmanial agents. Medicinal and aromatic plants constitute a major source of natural …

© 2007 Nature Publishing Group splenic or lymph node aspirate smears can be graded on
a logarithmic scale (from 0 to 6+), allowing the response to treatment to be evaluated, and …